Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome

Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome

Abstract Background RBM3 expression has been suggested as prognostic marker in several cancer types. The purpose of this study was to assess the prevalence and clinical significance of altered RBM3 expression in esophageal cancer. Methods RBM3 protein expression was measured by immunohistochemistry...

Full description

Bibliographic Details
Main Authors: Katharina Grupp, Bianca Hofmann, Asad Kutup, Kai Bachmann, Dean Bogoevski, Nathaniel Melling, Faik Guntac Uzunoglu, Alexander Tarek El Gammal, Christina Koop, Ronald Simon, Stefan Steurer, Till Krech, Susanne Burdak-Rothkamm, Frank Jacobsen, Guido Sauter, Jakob Izbicki, Waldemar Wilczak
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Cancer
Subjects:
RBM3
Tissue microarray
Prognosis
Esophageal cancer
Online Access:http://link.springer.com/article/10.1186/s12885-018-5032-z

Internet

http://link.springer.com/article/10.1186/s12885-018-5032-z

Similar Items